ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,735Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 224

$707K Total Retail Price of All Prescriptions

Rank: 3 out of 224

365 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 365 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

5% of this provider’s 365 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 8,822 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
METOPROLOL TARTRATE 562 526 1 7
SIMVASTATIN 502 446 2 1
HYDROCHLOROTHIAZIDE 441 412 3 6
METOPROLOL SUCCINATE 319 297 4 11
FUROSEMIDE 308 292 5 5
OMEPRAZOLE 300 263 6 3
AMLODIPINE BESYLATE 272 257 7 8
ATORVASTATIN CALCIUM 250 237 8 16
LISINOPRIL 215 199 9 2
SPIRIVA 198 166 10 32
FLOVENT HFA 194 167 11 86
ENALAPRIL MALEATE 181 165 12 42
CITALOPRAM HBR 178 151 13 15
LEVOTHYROXINE SODIUM 176 167 14 4
WARFARIN SODIUM 172 165 15 10
POTASSIUM CHLORIDE 163 159 16 24
GABAPENTIN 156 149 17 14
COMBIVENT 135 130 18 56
RANITIDINE HCL 132 116 19 29
PROAIR HFA 127 118 20 26
METFORMIN HCL 126 91 21 9
NEXIUM 126 108 21 34
ZOLPIDEM TARTRATE 123 110 23 22
DONEPEZIL HCL 116 116 24 36
LOSARTAN POTASSIUM 113 107 25 19
ALLOPURINOL 102 102 26 40
ISOSORBIDE MONONITRATE ER 98 95 27 70
NITROSTAT 94 84 28 133
POLYETHYLENE GLYCOL 3350 93 89 29 48
ALENDRONATE SODIUM 88 75 30 39
OXYCODONE HCL 87 84 S2 31 25
DILTIAZEM 24HR ER 86 77 32 84
TAMSULOSIN HCL 86 86 32 30
PANTOPRAZOLE SODIUM 84 76 34 27
OXYCODONE-ACETAMINOPHEN 83 59 S2 35 41
ADVAIR HFA 83 83 35 135
PREDNISONE 82 75 37 28
GLIPIZIDE XL 82 78 37 63
FINASTERIDE 72 72 39 83
NAMENDA 67 67 40 65
JANTOVEN 64 64 41 115
MECLIZINE HCL 61 61 42 127
ESCITALOPRAM OXALATE 60 51 43 64
DILTIAZEM 24HR CD 60 60 43 102
CHLORTHALIDONE 58 52 45 111
SERTRALINE HCL 57 46 46 17
LANTUS SOLOSTAR 56 35 47 60
CARVEDILOL 55 50 48 68
ADVAIR DISKUS 55 45 48 23
LANTUS 53 48 50 43
LIPITOR 53 51 50 94
GLYBURIDE 50 31 R 52 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.